Search
-
A Year in Review - 2020
This has been a year of momentous change – real and anticipated. As we pause to reflect at the end of the year, we present some Ipsos research highlights you may have missed during the dizzying events of 2020.
-
Global Vaccines Research
As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?
-
The COVID-19 pandemic eclipses climate risk
Ipsos today publishes the seventh edition of its Future Risks Report for Axa. This global study measures and ranks changes in the perception of emerging risks by a panel of risk management experts and the general public. Over 20,000 people were interviewed. Conducted in partnership with research institute Ipsos and geopolitical analysis consultancy Eurasia Group, this year’s ranking of the 10 main emerging risks is marked by the Covid-19 crisis.
-
What Worries the World: Coronavirus concern rebounds
46% of people around the world see Coronavirus as one of the top issues affecting their country today. Our latest What Worries the World survey shows spikes in concern in many nations.
-
Customer perspective: An Ipsos podcast
Customer Perspective is a weekly podcast exploring all things Customer Experience, performance of channels, and Mystery Shopping.
-
Signals #9: Understanding the coronavirus crisis
This ninth edition of our Signals digest brings together Ipsos’ latest research on coronavirus from our teams around the world.
-
World Refugee Day 2020
New global study shows increasing support for the principle of people seeking refuge from war or persecution but concerns about Coronavirus mean that half of those surveyed want their country to be less open to welcoming refugees.
-
Signals #8: Understanding the coronavirus crisis
This eighth edition of our Signals digest brings together Ipsos’ latest research on coronavirus from our teams around the world.